187 related articles for article (PubMed ID: 37777343)
1. Acne microbiome: From phyla to phylotypes.
Dreno B; Dekio I; Baldwin H; Demessant AL; Dagnelie MA; Khammari A; Corvec S
J Eur Acad Dermatol Venereol; 2024 Apr; 38(4):657-664. PubMed ID: 37777343
[TBL] [Abstract][Full Text] [Related]
2. The Skin Microbiome: A New Actor in Inflammatory Acne.
Dréno B; Dagnelie MA; Khammari A; Corvec S
Am J Clin Dermatol; 2020 Sep; 21(Suppl 1):18-24. PubMed ID: 32910436
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in understanding
Platsidaki E; Dessinioti C
F1000Res; 2018; 7():. PubMed ID: 30613388
[TBL] [Abstract][Full Text] [Related]
4. The increasing importance of the gut microbiome in acne vulgaris.
Siddiqui R; Makhlouf Z; Khan NA
Folia Microbiol (Praha); 2022 Dec; 67(6):825-835. PubMed ID: 35711021
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris.
Wang Y; Kuo S; Shu M; Yu J; Huang S; Dai A; Two A; Gallo RL; Huang CM
Appl Microbiol Biotechnol; 2014 Jan; 98(1):411-24. PubMed ID: 24265031
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway.
Mias C; Mengeaud V; Bessou-Touya S; Duplan H
J Eur Acad Dermatol Venereol; 2023 Mar; 37 Suppl 2():3-11. PubMed ID: 36729400
[TBL] [Abstract][Full Text] [Related]
7. Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris.
O'Neill AM; Gallo RL
Microbiome; 2018 Oct; 6(1):177. PubMed ID: 30285861
[TBL] [Abstract][Full Text] [Related]
8. Cutibacterium acnes (Propionibacterium acnes) and acne vulgaris: a brief look at the latest updates.
Dréno B; Pécastaings S; Corvec S; Veraldi S; Khammari A; Roques C
J Eur Acad Dermatol Venereol; 2018 Jun; 32 Suppl 2():5-14. PubMed ID: 29894579
[TBL] [Abstract][Full Text] [Related]
9. A Precision Microbiome Approach Using Sucrose for Selective Augmentation of Staphylococcus epidermidis Fermentation against Propionibacterium acnes.
Wang Y; Kao MS; Yu J; Huang S; Marito S; Gallo RL; Huang CM
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834859
[TBL] [Abstract][Full Text] [Related]
10. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
Farfán J; Gonzalez JM; Vives M
PeerJ; 2022; 10():e13553. PubMed ID: 35910763
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study.
Alkhawaja E; Hammadi S; Abdelmalek M; Mahasneh N; Alkhawaja B; Abdelmalek SM
BMC Dermatol; 2020 Nov; 20(1):17. PubMed ID: 33203374
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Intense Pulsed Light on the Skin Microbiota and Epidermal Barrier in Patients with Mild to Moderate Acne Vulgaris.
Liu J; Liu L; Zhou L; Chen L; Chen X; Xiong X; Deng Y
Lasers Surg Med; 2021 Dec; 53(10):1348-1355. PubMed ID: 34224604
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne?
Claudel JP; Auffret N; Leccia MT; Poli F; Corvec S; Dréno B
Dermatology; 2019; 235(4):287-294. PubMed ID: 31112983
[TBL] [Abstract][Full Text] [Related]
14. PEG-8 Laurate Fermentation of
Marito S; Keshari S; Huang CM
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32707723
[TBL] [Abstract][Full Text] [Related]
15. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response.
Dagnelie MA; Corvec S; Timon-David E; Khammari A; Dréno B
Exp Dermatol; 2022 Mar; 31(3):406-412. PubMed ID: 34674324
[TBL] [Abstract][Full Text] [Related]
16. Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies.
Omer H; McDowell A; Alexeyev OA
Clin Dermatol; 2017; 35(2):118-129. PubMed ID: 28274348
[TBL] [Abstract][Full Text] [Related]
17. Antagonism between Staphylococcus epidermidis and Propionibacterium acnes and its genomic basis.
Christensen GJ; Scholz CF; Enghild J; Rohde H; Kilian M; Thürmer A; Brzuszkiewicz E; Lomholt HB; Brüggemann H
BMC Genomics; 2016 Feb; 17():152. PubMed ID: 26924200
[TBL] [Abstract][Full Text] [Related]
18. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
[TBL] [Abstract][Full Text] [Related]
19. Skin barrier and microbiome in acne.
Rocha MA; Bagatin E
Arch Dermatol Res; 2018 Apr; 310(3):181-185. PubMed ID: 29147769
[TBL] [Abstract][Full Text] [Related]
20. Interference and co-existence of staphylococci and Cutibacterium acnes within the healthy human skin microbiome.
Ahle CM; Stødkilde K; Poehlein A; Bömeke M; Streit WR; Wenck H; Reuter JH; Hüpeden J; Brüggemann H
Commun Biol; 2022 Sep; 5(1):923. PubMed ID: 36071129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
